Position in IONS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$33,872,450
-$1,296,927 QoQ
Shares Held
427,197
-8.8% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#60
of 513 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. IONS ranks #20 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in IONS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,872,450 | 427,197 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $35,169,377 | 468,363 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $41,551,657 | 525,239 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,921,154 | 75,224 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,233,065 | 56,519 | Shares | Sole | 2025-08-13 | |
| 2024-09-30 | $16,116,138 | 402,300 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $771,806 | 16,194 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,623,444 | 175,858 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $55,534,160 | 1,097,730 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $51,482,647 | 1,134,979 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $54,284,002 | 1,323,032 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $58,575,822 | 1,638,943 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $67,265,839 | 1,780,933 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $91,877,209 | 2,077,260 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $59,085,956 | 1,596,055 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $59,867,381 | 1,616,290 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $51,122,765 | 1,680,012 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $56,365,613 | 1,680,549 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $60,730,490 | 1,522,449 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $52,504,692 | 1,167,809 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $78,417,078 | 1,386,931 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $66,321,481 | 1,397,713 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $77,544,604 | 1,315,207 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $45,032,923 | 952,473 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||